Maha H. Hussain, MD
Northwestern Medical GroupPrimary Specialty
Hematology and Medical Oncology
Is your insurance accepted? Select plan
Accepts your insurance
Does not accept your insurance
Based on January 2024 plan details.
Accepted plans are subject to change. To be sure this medical professional is covered by your insurance plan, please contact your insurance carrier.
HealthBeat
Clinical Trials Provide More Options for Cancer Care
Learn more about clinical trials near you.
Breakthrough Prostate Cancer Therapy Targets Genes to Delay Progression
Medication may transform treatment approach for men with castrate-resistant prostate cancer and genetic mutations.
More HealthBeat ArticlesPractice Focus Areas
This medical professional has a particular interest or expertise in:
Education
- Medical Education:
-
MD, University of Baghdad College of Medicine - 1980
- Residency:
-
Detroit Medical Center/Wayne State University - 1986
- Fellowships:
-
Wayne State University School of Medicine - 1989
Languages Spoken
- Arabic
Board Certifications
- American Board of Internal Medicine - Internal Medicine (Certified)
- American Board of Internal Medicine - Medical Oncology (Certified)
Faculty Profile
Professor, Feinberg School of MedicinePractice Groups and Affiliations
- Medical Group:
- Northwestern Medical Group
- Alignment Category:
-
Northwestern Medicine Physician Network
- On Medical Staff At:
-
Northwestern Memorial Hospital
Ratings and Reviews
At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.
Read Ratings FAQsOverall Rating
859 Ratings
Reviews from Patients
Reviews from Patients
April 24, 2025
5.0 star star star star starDr. Hussain consistently demonstrates an extraordinary commitment for providing exemplary, holistic oncological treatments. And she is so patient, always taking time to explain and answer my many questions.
February 06, 2025
5.0 star star star star starDr. Hussain and her oncology team are experienced and compassionate. You can tell she is a top expert in her field and wants to do the best for her patients. The whole team takes time to listen to my questions and answer them. They examine me and my test results and explain them to me. (Translate from medical terminology to everyday language.) They then choose the best course of recognized (by FDA and medical expert community and insurance) gold standard treatment and adjust as needed. While I am not cured of the cancer, they are pleased with the results of my treatment. They have explained how the course of my future care should generally unfold.
November 03, 2024
5.0 star star star star starDr Maha Hussain is the best in Nation and well known worldwide. She is very careful and very confident in her approach, listens to patients in very details answers all questions. Patients have lots of confidence in Dr Hussain
September 21, 2024
5.0 star star star star starI liked her outgoing personality, her genuine concern for my welfare and the fact that she didn't make me feel like she was rushing through my appointment but was willing to spend as long as was necessary to answer my questions.
Disclosures
Industry Relationships
Consulting
Faculty member and/or their immediate family have engaged in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities
- American Society for Clinical Investigation, Inc.
- Ascension
- AstraZeneca
- Bayer HealthCare Pharmaceuticals, Inc.
- Brazilian Society of Urology
- Convergent
- Digital Science Press, Inc.
- Medscape Continuing Medical Education (CME)
- MJH Life Sciences
- Physician Education Resource, LLC (PER)
- Research To Practice (RTP)
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.
HealthBeat
Clinical Trials Provide More Options for Cancer Care
Learn more about clinical trials near you.
Breakthrough Prostate Cancer Therapy Targets Genes to Delay Progression
Medication may transform treatment approach for men with castrate-resistant prostate cancer and genetic mutations.
More HealthBeat Articles